Atai is top a scientific trial in the United Kingdom on an ibogaine-derived therapy for opioid withdrawal and relapse avoidance. Generally known as the “anti-dependancy drug,” ibogaine is usually a psychoactive drug located in the roots of the Tabernanthe iboga shrub indigenous to Central Africa. For advocates, that study offers the most